Your browser doesn't support javascript.
loading
Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et al.
Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael.
Afiliación
  • Bonaventura J; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, Catalonia, Spain. jbonaventura@ub.edu.
  • Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. jbonaventura@ub.edu.
  • Carlton M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Boehm M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Solís O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Sánchez-Soto M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Morris PJ; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, USA.
  • Fredriksson I; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, USA.
  • Thomas CJ; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Sibley DR; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, USA.
  • Shaham Y; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, USA.
  • Zarate CA; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • Michaelides M; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.
Mol Psychiatry ; 27(4): 1863-1865, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35194167
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: España